Community update from Roche

We are happy to share the latest Community Letter issued by Roche.
We are happy to share the latest Community Letter issued by Roche.
We are pleased to share with you the latest Community Update from Biogen.
Background and Objectives of the publication.
Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder associated with continuous motor function loss and complications, such as scoliosis and contractures. Understanding the natural history of SMA is key to demonstrating the long-term outcomes of SMA treatments. This study reviews the natural history of motor function, scoliosis, and contractures in patients with SMA.
We are pleased to share the latest community update from Roche with several topics that are relevant to our SMA Community.